Enable JavaScript to visit this website.

The time is now to begin the next phase of the breast cancer movement, where all people living with breast cancer – the early, the advanced and the metastatic – feel equally embraced.

Click below to learn more about the photo essay initiative.

The Initiative

About Story Half Told

AboutStory Half Told

Breast Cancer: A Story Half Told is an initiative by Pfizer in partnership with advocates, patients and healthcare professionals that aims to elevate public understanding of metastatic breast cancer, dispel misperceptions, combat stigma and expand the breast cancer conversation to be more inclusive of metastatic breast cancer.

The initiative launched in 2014 to spotlight the misperceptions that surround metastatic breast cancer and focused on supporting people with breast cancer, including those with metastatic disease, in multiple aspects of their lives - the doctor's office, the workplace and in society at large. This new chapter aims to address the lack of understanding of metastatic breast cancer by featuring those living with this disease, chronicled by well known photographers.

AboutMetastatic Breast Cancer

Awareness of Early Stage Breast Cancer Is High, but Knowledge of Metastatic Breast Cancer Is Low

Metastatic breast cancer is the most advanced stage of breast cancer (stage IV), in which cancer has spread beyond the breast to other organs in the body. Even when diagnosed at an early stage, up to 30 percent of women with early stage breast cancer will eventually progress to metastatic disease.2 The median survival rate for metastatic breast cancer is estimated to be 3 years.3 However, every metastatic breast cancer patient is unique and therefore experiences may vary. Males also have breast cells and tissue. These cells and tissue can develop cancer.

Rather than a single disease with uniform characteristics, breast cancer embodies many diseases, each with different biological and clinical traits. This is even the case within the different stages of breast cancer.

The emotional toll of metastatic disease can be profound, and can transcend into the ways people feel about themselves, communicate with others, and live their lives.4,5 If you want to learn more about metastatic breast cancer, see the Story Half Told Resources Page

Despite its prevalence, a survey of more than 2,000 adults1 found that

About ThePhoto Essay Initiative

As part of the initiative, Pfizer has commissioned well known photographers to capture the daily lives of people living with metastatic breast cancer. While these photographs document the realities of metastatic breast cancer, their purpose is to show how people with metastatic breast cancer are living their lives to the fullest.

Meet the participants

1 Source: National Omnibus Breast Cancer Survey, sponsored by Pfizer Oncology, April 2014.

2 Source: O'Shaughnessy J. Extending survival with chemotherapy in metastatic breast cancer. The Oncologist. 2005.

3 Source: American Society of Clinical Oncology. Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment, April 2008.

4 Source: Pfizer Inc. Bridging Gaps, Expanding Outreach – MBC Patient Survey. 2009.

5 Source: Mayer M, Grober S. Silent voices: women with advanced (metastatic) breast cancer share their needs and preferences for information, support and practical services. Research Report. Living Beyond Breast Cancer. 2006.

Find Out More

Meet the Participants
Meet the Photographers

Click Below to Explore the Work Being Done byOur Partners in Metastatic Breast Cancer